Taconic Capital Advisors’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Taconic Capital Advisors’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-39,302	Closed	-$8.65K	–	394
2022 Q4	$8.65K	Sell	39,302 -23,498	-37%	-$20.4K	﹤0.01%	433
2022 Q3	$166K	Sell	62,800 -72,200	-53%	-$106K	﹤0.01%	401
2022 Q2	$92K	Sell	135,000 -10,000	-7%	-$10.4K	﹤0.01%	436
2022 Q1	$229K	Sell	145,000 -13,375	-8%	-$19.3K	0.01%	426
2021 Q4	$379K	Hold	158,375	–	–	0.01%	345
2021 Q3	$654K	Sell	158,375 -8,291	-5%	-$31.2K	0.02%	266
2021 Q2	$615K	Buy	+166,666	New	+$753K	0.01%	286

Other funds holding CANO.WS

Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

DKP

Davidson Kempner Partners New York $5.16B AUM

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Taconic Capital Advisors's CANO.WS Position: Q1 2023 in Review

Taconic Capital Advisors sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q1 2023, closing a stake of 39,302 shares — an estimated $8.65K sold.

Taconic Capital Advisors first reported a position in CANO.WS in Q2 2021 and held it in 7 quarters. The position peaked at $654K in Q3 2021. 20 funds tracked by Wall St. Rank hold CANO.WS as of Q1 2023.

Taconic Capital Advisors reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q1 2023 after selling out during the quarter.
Taconic Capital Advisors sold 39,302 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q1 2023, an estimated $8.65K.
Taconic Capital Advisors first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 7 quarters.
Taconic Capital Advisors's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $654K in Q3 2021.
20 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q1 2023.

Based on Taconic Capital Advisors's 13F filing for Q1 2023, filed 15 May 2023.